[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519593":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":11,"responsibleParty":29,"collaborators":31,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":11,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":46,"minAge":47,"maxAge":11,"enrollmentInfo":48,"targetDuration":11,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":11,"overallStatus":57,"whyStopped":11,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":11},{"fullName":5,"class":6},"Galzu Institute of Research, Teaching, Science and Applied Technology","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"women diagnosed with breast cancer before cancer treatment","EXPERIMENTAL",null,[13],"Device: VTM examination and breast biopsy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","VTM examination and breast biopsy","VTM examination performed by a radiologist, at the MART (Metabolic Activity in Real-Time) station, using the SaMD Mart 2.0, according to the inspection protocol to identify breast alterations and\u002For suspicious images to be biopsied for validation by genetic tests and histology \u002F immunohistochemistry.",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Paula GA Cabral, PhD","CONTACT","5522999857370","pgacabral99@gmail.com",{"name":27,"role":23,"phone":24,"phoneExt":11,"email":28},"Savio B Souza, PhD","saviobas@gmail.com",{"type":30,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[32,35,37],{"name":33,"class":34},"Hospital Santa Casa de Misericordia de Campos","UNKNOWN",{"name":36,"class":34},"Hospital Escola Alvaro Alvim",{"name":38,"class":34},"Universidade Estadual do Norte Fluminense (UENF)","100519593","vascular-supply-identification-lesion-extension-and-search-for-tumor-similarity-at-a-distance-by-vtm-in-breast-cancer-100519593",false,"NCT06045572","Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast Cancer","Inclusion Criteria:\n\nWomen ≥18 years old; Women with breast cancer before oncological treatment; Voluntary signature of the Free and Informed Consent Term.\n\nExclusion Criteria:\n\nPregnant or lactating women; Patients already included in other clinical trials; Patients who are undergoing radiotherapy, chemotherapy or post-cancer surgery treatment; Patients who need urgent or emergency care; Patients with fever or other illness that affects the integrity of the skin; Any clinically significant medical condition or medical history that, in the opinion of the investigator, may discourage participation in the study.",true,"FEMALE","18 Years",{"count":49,"type":50},120,"ESTIMATED","INTERVENTIONAL",[53],"NA","When we talk about early identification, we are talking about an ALREADY EXISTING INJURY, triggering a change in the patient's quality of life and a projection of future costs for the health system.\n\nINNOVATIVE ASPECT: While screening mammography identifies an existing lesion, VTM could: Make an early diagnosis before the formation of a visible or palpable tumor mass; Check the metabolic activity in suspicious lesions identified by other diagnostic methods; Demarcate tumor range and tumor similarity from a distance in breast cancer.\n\nRegarding the Risk x Benefit:There are no medications incorporated, associated or administered by the equipment; There is no ionizing radiation incorporated or delivered by the equipment; There are no contraindications for the use of the equipment by the patient (Non-ionizing infrared radiation, without contrast or contact); Audience destined to operate the equipment: Physician \u002F Radiologist with training Therefore, the research in question is of great relevance for such a debilitating health problem for the patient and for the health system.",[56],"Breast Cancer Female","NOT_YET_RECRUITING","2026-01-09",{"date":60,"type":61},"2026-01-12","ACTUAL",{"date":63,"type":50},"2026-06-01",{"date":65,"type":50},"2027-06-01",{"name":5,"class":6}]